Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Epigenetic activity silences Rb2/P130 gene in lung cancer

13.09.2005


Simple test could be developed to determine cancerous or pre-cancerous conditions



The attaching of methyl--or chemical--groups onto DNA sequences within the tumor suppressing gene Rb2/p130 can cause the gene to cease functioning in non-small lung cancer cells (NSLC) and retinoblastoma cells, researchers at Temple University’s Sbarro Institute for Cancer Research and Molecular Medicine and Italy’s University of Siena have discovered.

Their findings are reported in two studies: "Tumor-specific exon 1 mutations could be the ’hit event’ predisposing Rb2/p130 gene to epigenetic silencing in lung cancer" and "Genetic and epigenetic alterations of RB2/p130 tumor suppressor gene in human sporadic retinoblastoma: implications for pathogenesis and therapeutic approach," both of which appear in September issues of Oncogene (www.nature.com/onc).


The joint studies at Temple and Siena were coordinated by Antonio Giordano, M.D., Ph.D., director of Sbarro Institute at Temple (www.shro.org), and by Marcella Macaluso of the Sbarro Institute and Caterina Cinti of both Centro Nazionale Ricerche and the University of Siena.

Giordano said that the researchers were puzzled when they found Rb2/130, the tumor suppressing gene discovered by Giordano in the early 1990s, in an epigenetic state in both the NSLC and retinoblastoma cells. In this epigenetic state, the gene showed no signs of mutation, but is silent in its expression or function.

Further examination of the gene found that it had been methylated, a process in which methyl or chemical groups attached themselves to the gene, attacking a sequence of the Rb2/p130’s DNA and thus causing it to cease functioning.

"These studies are providing very important information on how cancerous and pre-cancerous conditions can be detected by the presence of the methylated state of Rb2/p130," said Giordano. "These cancerous or pre-cancerous conditions can be treated with drugs or agents that de-methylate the Rb2/p130 gene. Once the drugs or agents disconnect the methyl groups from Rb2/p130, the gene begins to again express itself or function normally."

He likened this methylation/de-methylation phenomenon--which can stop or start the expression of a gene--to a lightswitch which is used to turn a lamp off or on.

Giordano said some of these agents that will de-methylate Rb2 are already available, but have not been previously used because researchers did not know that the lack of expression from the gene was being caused by its methylation.

"Our discovery is providing a smart method to identify novel methylated drugs or agents that can assist in restarting the vital expression of Rb2/p130," he said.

Through the use of a simple genetic (both at DNA and Protein level) test of Rb2 gene and protein from a human tissue sample, said Giordano, scientists could determine if cancerous or pre-cancerous conditions exist because of the epigenetic state of the gene.

"We could develop a potential test which could save many, many people from the ravages of cancer," he said.

Preston M. Moretz | EurekAlert!
Further information:
http://www.temple.edu
http://www.nature.com/onc
http://www.shro.org

More articles from Life Sciences:

nachricht New catalyst controls activation of a carbon-hydrogen bond
21.11.2017 | Emory Health Sciences

nachricht The main switch
21.11.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Nanoparticles help with malaria diagnosis – new rapid test in development

The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.

Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

Im Focus: Researchers Develop Data Bus for Quantum Computer

The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.

Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

Previous evidence of water on mars now identified as grainflows

21.11.2017 | Physics and Astronomy

NASA's James Webb Space Telescope completes final cryogenic testing

21.11.2017 | Physics and Astronomy

New catalyst controls activation of a carbon-hydrogen bond

21.11.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>